Loading…

Synthetic molecules for disruption of the MYC protein-protein interface

[Display omitted] MYC is a key transcriptional regulator involved in cellular proliferation and has established roles in transcriptional elongation and initiation, microRNA regulation, apoptosis, and pluripotency. Despite this prevalence, functional chemical probes of MYC function at the protein lev...

Full description

Saved in:
Bibliographic Details
Published in:Bioorganic & medicinal chemistry 2018-08, Vol.26 (14), p.4234-4239
Main Authors: Jacob, Nicholas T., Miranda, Pedro O., Shirey, Ryan J., Gautam, Ritika, Zhou, Bin, de Orbe Izquierdo, M. Elena, Hixon, Mark S., Hart, Jonathan R., Ueno, Lynn, Vogt, Peter K., Janda, Kim D.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c451t-fd5c86e22d4a0120e221b5b13fd9c1933fd232a6e5c707d37906aa413ef7cbdd3
cites cdi_FETCH-LOGICAL-c451t-fd5c86e22d4a0120e221b5b13fd9c1933fd232a6e5c707d37906aa413ef7cbdd3
container_end_page 4239
container_issue 14
container_start_page 4234
container_title Bioorganic & medicinal chemistry
container_volume 26
creator Jacob, Nicholas T.
Miranda, Pedro O.
Shirey, Ryan J.
Gautam, Ritika
Zhou, Bin
de Orbe Izquierdo, M. Elena
Hixon, Mark S.
Hart, Jonathan R.
Ueno, Lynn
Vogt, Peter K.
Janda, Kim D.
description [Display omitted] MYC is a key transcriptional regulator involved in cellular proliferation and has established roles in transcriptional elongation and initiation, microRNA regulation, apoptosis, and pluripotency. Despite this prevalence, functional chemical probes of MYC function at the protein level have been limited. Previously, we discovered 5a, that binds to MYC with potency and specificity, downregulates the transcriptional activities of MYC and shows efficacy in vivo. However, this scaffold posed intrinsic pharmacokinetic liabilities, namely, poor solubility that precluded biophysical interrogation. Here, we developed a screening platform based on field-effect transistor analysis (Bio-FET), surface plasmon resonance (SPR), and a microtumor formation assay to analyze a series of new compounds aimed at improving these properties. This blind SAR campaign has produced a new lead compound of significantly increased in vivo stability and solubility for a 40-fold increase in exposure. This probe represents a significant advancement that will not only enable biophysical characterization of this interaction and further SAR, but also contribute to advances in understanding of MYC biology.
doi_str_mv 10.1016/j.bmc.2018.07.019
format article
fullrecord <record><control><sourceid>elsevier_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6214403</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0968089618310319</els_id><sourcerecordid>S0968089618310319</sourcerecordid><originalsourceid>FETCH-LOGICAL-c451t-fd5c86e22d4a0120e221b5b13fd9c1933fd232a6e5c707d37906aa413ef7cbdd3</originalsourceid><addsrcrecordid>eNp9kE9Lw0AQxRdRbK1-AC-SL5A4k81fBEGKVqHiQT14Wja7E7slyZZNWui3d0ur6MXTG5j33jA_xi4RIgTMrpdR1aooBiwiyCPA8oiNMcmSkPMSj9kYyqwIoSizETvr-yUAxEmJp2zEAXiep3zMZq_bbljQYFTQ2obUuqE-qK0LtOndejUY2wW2DrwleP6YBitnBzJdeNDAdAO5Wio6Zye1bHq6OOiEvT_cv00fw_nL7Gl6Nw9VkuIQ1jpVRUZxrBMJGIOfsEor5LUuFZbca8xjmVGqcsg1z0vIpEyQU52rSms-Ybf73tW6akkr6gYnG7FyppVuK6w04u-mMwvxaTciizFJgPsC3BcoZ_veUf2TRRA7qmIpPFWxoyogF56qz1z9PvqT-MboDTd7A_nXN4ac6JWhTpE2jtQgtDX_1H8BK-aKIA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Synthetic molecules for disruption of the MYC protein-protein interface</title><source>ScienceDirect Journals</source><creator>Jacob, Nicholas T. ; Miranda, Pedro O. ; Shirey, Ryan J. ; Gautam, Ritika ; Zhou, Bin ; de Orbe Izquierdo, M. Elena ; Hixon, Mark S. ; Hart, Jonathan R. ; Ueno, Lynn ; Vogt, Peter K. ; Janda, Kim D.</creator><creatorcontrib>Jacob, Nicholas T. ; Miranda, Pedro O. ; Shirey, Ryan J. ; Gautam, Ritika ; Zhou, Bin ; de Orbe Izquierdo, M. Elena ; Hixon, Mark S. ; Hart, Jonathan R. ; Ueno, Lynn ; Vogt, Peter K. ; Janda, Kim D.</creatorcontrib><description>[Display omitted] MYC is a key transcriptional regulator involved in cellular proliferation and has established roles in transcriptional elongation and initiation, microRNA regulation, apoptosis, and pluripotency. Despite this prevalence, functional chemical probes of MYC function at the protein level have been limited. Previously, we discovered 5a, that binds to MYC with potency and specificity, downregulates the transcriptional activities of MYC and shows efficacy in vivo. However, this scaffold posed intrinsic pharmacokinetic liabilities, namely, poor solubility that precluded biophysical interrogation. Here, we developed a screening platform based on field-effect transistor analysis (Bio-FET), surface plasmon resonance (SPR), and a microtumor formation assay to analyze a series of new compounds aimed at improving these properties. This blind SAR campaign has produced a new lead compound of significantly increased in vivo stability and solubility for a 40-fold increase in exposure. This probe represents a significant advancement that will not only enable biophysical characterization of this interaction and further SAR, but also contribute to advances in understanding of MYC biology.</description><identifier>ISSN: 0968-0896</identifier><identifier>EISSN: 1464-3391</identifier><identifier>DOI: 10.1016/j.bmc.2018.07.019</identifier><identifier>PMID: 30037753</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Dose-Response Relationship, Drug ; Humans ; Hydrophobic and Hydrophilic Interactions ; Molecular Structure ; Protein Binding - drug effects ; Proto-Oncogene Proteins c-myc - antagonists &amp; inhibitors ; Proto-Oncogene Proteins c-myc - metabolism ; Pyridines - chemical synthesis ; Pyridines - chemistry ; Pyridines - pharmacology ; Pyrimidines - chemical synthesis ; Pyrimidines - chemistry ; Pyrimidines - pharmacology ; Solubility ; Structure-Activity Relationship ; Surface Plasmon Resonance</subject><ispartof>Bioorganic &amp; medicinal chemistry, 2018-08, Vol.26 (14), p.4234-4239</ispartof><rights>2018 Elsevier Ltd</rights><rights>Copyright © 2018 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c451t-fd5c86e22d4a0120e221b5b13fd9c1933fd232a6e5c707d37906aa413ef7cbdd3</citedby><cites>FETCH-LOGICAL-c451t-fd5c86e22d4a0120e221b5b13fd9c1933fd232a6e5c707d37906aa413ef7cbdd3</cites><orcidid>0000-0002-2064-9160</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30037753$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jacob, Nicholas T.</creatorcontrib><creatorcontrib>Miranda, Pedro O.</creatorcontrib><creatorcontrib>Shirey, Ryan J.</creatorcontrib><creatorcontrib>Gautam, Ritika</creatorcontrib><creatorcontrib>Zhou, Bin</creatorcontrib><creatorcontrib>de Orbe Izquierdo, M. Elena</creatorcontrib><creatorcontrib>Hixon, Mark S.</creatorcontrib><creatorcontrib>Hart, Jonathan R.</creatorcontrib><creatorcontrib>Ueno, Lynn</creatorcontrib><creatorcontrib>Vogt, Peter K.</creatorcontrib><creatorcontrib>Janda, Kim D.</creatorcontrib><title>Synthetic molecules for disruption of the MYC protein-protein interface</title><title>Bioorganic &amp; medicinal chemistry</title><addtitle>Bioorg Med Chem</addtitle><description>[Display omitted] MYC is a key transcriptional regulator involved in cellular proliferation and has established roles in transcriptional elongation and initiation, microRNA regulation, apoptosis, and pluripotency. Despite this prevalence, functional chemical probes of MYC function at the protein level have been limited. Previously, we discovered 5a, that binds to MYC with potency and specificity, downregulates the transcriptional activities of MYC and shows efficacy in vivo. However, this scaffold posed intrinsic pharmacokinetic liabilities, namely, poor solubility that precluded biophysical interrogation. Here, we developed a screening platform based on field-effect transistor analysis (Bio-FET), surface plasmon resonance (SPR), and a microtumor formation assay to analyze a series of new compounds aimed at improving these properties. This blind SAR campaign has produced a new lead compound of significantly increased in vivo stability and solubility for a 40-fold increase in exposure. This probe represents a significant advancement that will not only enable biophysical characterization of this interaction and further SAR, but also contribute to advances in understanding of MYC biology.</description><subject>Dose-Response Relationship, Drug</subject><subject>Humans</subject><subject>Hydrophobic and Hydrophilic Interactions</subject><subject>Molecular Structure</subject><subject>Protein Binding - drug effects</subject><subject>Proto-Oncogene Proteins c-myc - antagonists &amp; inhibitors</subject><subject>Proto-Oncogene Proteins c-myc - metabolism</subject><subject>Pyridines - chemical synthesis</subject><subject>Pyridines - chemistry</subject><subject>Pyridines - pharmacology</subject><subject>Pyrimidines - chemical synthesis</subject><subject>Pyrimidines - chemistry</subject><subject>Pyrimidines - pharmacology</subject><subject>Solubility</subject><subject>Structure-Activity Relationship</subject><subject>Surface Plasmon Resonance</subject><issn>0968-0896</issn><issn>1464-3391</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kE9Lw0AQxRdRbK1-AC-SL5A4k81fBEGKVqHiQT14Wja7E7slyZZNWui3d0ur6MXTG5j33jA_xi4RIgTMrpdR1aooBiwiyCPA8oiNMcmSkPMSj9kYyqwIoSizETvr-yUAxEmJp2zEAXiep3zMZq_bbljQYFTQ2obUuqE-qK0LtOndejUY2wW2DrwleP6YBitnBzJdeNDAdAO5Wio6Zye1bHq6OOiEvT_cv00fw_nL7Gl6Nw9VkuIQ1jpVRUZxrBMJGIOfsEor5LUuFZbca8xjmVGqcsg1z0vIpEyQU52rSms-Ybf73tW6akkr6gYnG7FyppVuK6w04u-mMwvxaTciizFJgPsC3BcoZ_veUf2TRRA7qmIpPFWxoyogF56qz1z9PvqT-MboDTd7A_nXN4ac6JWhTpE2jtQgtDX_1H8BK-aKIA</recordid><startdate>20180807</startdate><enddate>20180807</enddate><creator>Jacob, Nicholas T.</creator><creator>Miranda, Pedro O.</creator><creator>Shirey, Ryan J.</creator><creator>Gautam, Ritika</creator><creator>Zhou, Bin</creator><creator>de Orbe Izquierdo, M. Elena</creator><creator>Hixon, Mark S.</creator><creator>Hart, Jonathan R.</creator><creator>Ueno, Lynn</creator><creator>Vogt, Peter K.</creator><creator>Janda, Kim D.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-2064-9160</orcidid></search><sort><creationdate>20180807</creationdate><title>Synthetic molecules for disruption of the MYC protein-protein interface</title><author>Jacob, Nicholas T. ; Miranda, Pedro O. ; Shirey, Ryan J. ; Gautam, Ritika ; Zhou, Bin ; de Orbe Izquierdo, M. Elena ; Hixon, Mark S. ; Hart, Jonathan R. ; Ueno, Lynn ; Vogt, Peter K. ; Janda, Kim D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c451t-fd5c86e22d4a0120e221b5b13fd9c1933fd232a6e5c707d37906aa413ef7cbdd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Dose-Response Relationship, Drug</topic><topic>Humans</topic><topic>Hydrophobic and Hydrophilic Interactions</topic><topic>Molecular Structure</topic><topic>Protein Binding - drug effects</topic><topic>Proto-Oncogene Proteins c-myc - antagonists &amp; inhibitors</topic><topic>Proto-Oncogene Proteins c-myc - metabolism</topic><topic>Pyridines - chemical synthesis</topic><topic>Pyridines - chemistry</topic><topic>Pyridines - pharmacology</topic><topic>Pyrimidines - chemical synthesis</topic><topic>Pyrimidines - chemistry</topic><topic>Pyrimidines - pharmacology</topic><topic>Solubility</topic><topic>Structure-Activity Relationship</topic><topic>Surface Plasmon Resonance</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jacob, Nicholas T.</creatorcontrib><creatorcontrib>Miranda, Pedro O.</creatorcontrib><creatorcontrib>Shirey, Ryan J.</creatorcontrib><creatorcontrib>Gautam, Ritika</creatorcontrib><creatorcontrib>Zhou, Bin</creatorcontrib><creatorcontrib>de Orbe Izquierdo, M. Elena</creatorcontrib><creatorcontrib>Hixon, Mark S.</creatorcontrib><creatorcontrib>Hart, Jonathan R.</creatorcontrib><creatorcontrib>Ueno, Lynn</creatorcontrib><creatorcontrib>Vogt, Peter K.</creatorcontrib><creatorcontrib>Janda, Kim D.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Bioorganic &amp; medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jacob, Nicholas T.</au><au>Miranda, Pedro O.</au><au>Shirey, Ryan J.</au><au>Gautam, Ritika</au><au>Zhou, Bin</au><au>de Orbe Izquierdo, M. Elena</au><au>Hixon, Mark S.</au><au>Hart, Jonathan R.</au><au>Ueno, Lynn</au><au>Vogt, Peter K.</au><au>Janda, Kim D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthetic molecules for disruption of the MYC protein-protein interface</atitle><jtitle>Bioorganic &amp; medicinal chemistry</jtitle><addtitle>Bioorg Med Chem</addtitle><date>2018-08-07</date><risdate>2018</risdate><volume>26</volume><issue>14</issue><spage>4234</spage><epage>4239</epage><pages>4234-4239</pages><issn>0968-0896</issn><eissn>1464-3391</eissn><abstract>[Display omitted] MYC is a key transcriptional regulator involved in cellular proliferation and has established roles in transcriptional elongation and initiation, microRNA regulation, apoptosis, and pluripotency. Despite this prevalence, functional chemical probes of MYC function at the protein level have been limited. Previously, we discovered 5a, that binds to MYC with potency and specificity, downregulates the transcriptional activities of MYC and shows efficacy in vivo. However, this scaffold posed intrinsic pharmacokinetic liabilities, namely, poor solubility that precluded biophysical interrogation. Here, we developed a screening platform based on field-effect transistor analysis (Bio-FET), surface plasmon resonance (SPR), and a microtumor formation assay to analyze a series of new compounds aimed at improving these properties. This blind SAR campaign has produced a new lead compound of significantly increased in vivo stability and solubility for a 40-fold increase in exposure. This probe represents a significant advancement that will not only enable biophysical characterization of this interaction and further SAR, but also contribute to advances in understanding of MYC biology.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>30037753</pmid><doi>10.1016/j.bmc.2018.07.019</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-2064-9160</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0968-0896
ispartof Bioorganic & medicinal chemistry, 2018-08, Vol.26 (14), p.4234-4239
issn 0968-0896
1464-3391
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6214403
source ScienceDirect Journals
subjects Dose-Response Relationship, Drug
Humans
Hydrophobic and Hydrophilic Interactions
Molecular Structure
Protein Binding - drug effects
Proto-Oncogene Proteins c-myc - antagonists & inhibitors
Proto-Oncogene Proteins c-myc - metabolism
Pyridines - chemical synthesis
Pyridines - chemistry
Pyridines - pharmacology
Pyrimidines - chemical synthesis
Pyrimidines - chemistry
Pyrimidines - pharmacology
Solubility
Structure-Activity Relationship
Surface Plasmon Resonance
title Synthetic molecules for disruption of the MYC protein-protein interface
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T21%3A01%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthetic%20molecules%20for%20disruption%20of%20the%20MYC%20protein-protein%20interface&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry&rft.au=Jacob,%20Nicholas%20T.&rft.date=2018-08-07&rft.volume=26&rft.issue=14&rft.spage=4234&rft.epage=4239&rft.pages=4234-4239&rft.issn=0968-0896&rft.eissn=1464-3391&rft_id=info:doi/10.1016/j.bmc.2018.07.019&rft_dat=%3Celsevier_pubme%3ES0968089618310319%3C/elsevier_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c451t-fd5c86e22d4a0120e221b5b13fd9c1933fd232a6e5c707d37906aa413ef7cbdd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/30037753&rfr_iscdi=true